Target intelligence / Profile preview

Cytochrome b5 reductase (null)

Target
null
Molecular classification
Enzyme, Oxidoreductase
01

Overview

Cytochrome b5 reductase is an oxidoreductase enzyme present in all cells but primarily functionally important in erythrocytes, where it is also known as "methemoglobin reductase." Its main physiological role in red blood cells is to catalyze the reduction of methemoglobin (Fe^3+) to functional hemoglobin (Fe^2+) using electrons from NADH. This process is essential for maintaining the oxygen-carrying capacity of blood by limiting the accumulation of methemoglobin, which cannot bind oxygen. Deficiency in cytochrome b5 reductase activity results in methemoglobinemia, a condition characterized by impaired oxygen delivery and cyanosis. While cytochrome b5 reductase has critical roles in lipid metabolism across tissues, its "methemoglobin reductase" function is vital in erythrocytes[1][3][4].

Other names
Methemoglobin reductaseNADH-cytochrome b5 reductaseDiaphorase 1CYB5RB5R
02

Mechanism of action

Methylene blue acts by accepting electrons from NADPH and promoting reduction of methemoglobin (via NADPH-methemoglobin reductase pathway)[3][4] Ascorbic acid and glutathione act as non-enzymatic reducing agents for methemoglobin[3]

03

Biological functions

Reduction of methemoglobin to hemoglobinElectron transportLipid metabolism (elongation/desaturation of fatty acids)Cholesterol biosynthesis[1][3]
04

Disease associations

Methemoglobinemia (hereditary and acquired)[4]Other, such as rare inherited cytochrome b5 reductase deficiency syndromes
05

Safety considerations

Cytochrome b5 reductase (methemoglobin reductase) deficiency leads to susceptibility to methemoglobinemiaSome individuals with reduced enzyme activity may experience hemolysis if treated with oxidant drugs or methylene blue[4]
06

Interacting drugs

Methylene blue[3][4]

3 more in the full profile.

07

Biomarkers

Methemoglobin levels (used for diagnosis and efficacy monitoring in methemoglobinemia)[4]

Beyond the preview

Go deeper on Cytochrome b5 reductase (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b5 reductase (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call